The application of metabonomic science to interrogate stroke permits the study of metabolite entities, small enough to cross the blood-brain barrier, that provide insight into neuronal dysfunction, and may serve as reservoirs of biomarker discovery. This systematic review examines the applicability of metabolic profiling in ischemic stroke research. Six human studies utilizing metabolic profiling to analyze biofluids from ischemic stroke patients have been included, employing 1H-NMR and/or mass spectrometry to analyze plasma, serum, and/or urine in a targeted or untargeted fashion. Three are diagnostic studies, and one investigates prognostic biomarkers of stroke recurrence following transient ischemic attack. Two studies focus on metabolic distinguishers of depression or cognitive impairment following stroke. Identified biomarkers from blood and urine predominantly relate to homocysteine and folate, branched chain amino acid, and lipid metabolism. Statistical models are well fitted and reproducible, with excellent validation outcomes, demonstrating the feasibility of metabolic profiling to study a complex disorder with multicausal pathology, such as stroke.
AdibhatlaRMHatcherJF. 2008. Altered lipid metabolism in brain injury and disorders. Subcell Biochem49:241–68.
2.
AnsariRMahtaAMallackELuoJJ. 2014. Hyperhomo-cysteinemia and neurologic disorders: a review. J Clin Neurol10(4):281–8.
3.
CacciapuotiF. 2013. Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer’s disease. J Thromb Thrombolysis36(3):258–62.
4.
DingXLiuRLiWNiHLiuYWuD, and others. 2016. A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD). Metab Brain Dis31(2):279–87.
EnglandTJHindWHRasidNAO’SullivanSE. 2015. Cannabinoids in experimental stroke: a systematic review and meta-analysis. J Cereb Blood Flow Metab35(3):348–58.
7.
EspositoECordaroMCuzzocreaS. 2014. Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. Pharmacol Res86:26–31.
8.
GaoJYangHChenJFangJChenCLiangR, and others. 2013. Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia. Mol Biosyst9(9):2311–21.
9.
HillardCJ. 2008. Role of cannabinoids and endocannabinoids in cerebral ischemia. Curr Pharm Des14(23):2347–61.
10.
HilleredLKotwicaZUngerstedtU. 1991. Interstitial and cerebrospinal fluid levels of energy-related metabolites after middle cerebral artery occlusion in rats. Res Exp Med (Berl)191(3):219–25.
11.
Homocysteine Studies Collaboration. 2002. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA288(16):2015–22.
12.
HuangYZhouMSunHWangY. 2011. Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?Cardiovasc Res90(2):220–3.
13.
IrieMFujimuraYYamatoMMiuraDWariishiH. 2014. Integrated MALDI-MS imaging and LC-MS techniques for visualizing spatiotemporal metabolomic dynamics in a rat stroke model. Metabolomics10(3):473–83.
14.
IssaqHJAbbottEVeenstraTD. 2008. Utility of separation science in metabolomic studies. J Sep Sci31(11):1936–47.
15.
JiangZSunJLiangQCaiYLiSHuangY, and others. 2011. A metabonomic approach applied to predict patients with cerebral infarction. Talanta84(2):298–304.
16.
JoveMMauri-CapdevilaGSuarezICambraySSanahujaJQuilezA, and others. 2015. Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology84(1):36–45.
17.
JungJYLeeHSKangDGKimNSChaMHBangOS, and others. 2011. 1H-NMR-based metabolomics study of cerebral infarction. Stroke42(5):1282–8.
18.
KimberlyWTWangYPhamLFurieKLGersztenRE. 2013. Metabolite profiling identifies a branched chain amino acid signature in acute cardioembolic stroke. Stroke44(5):1389–95.
19.
LaskowitzDTKasnerSESaverJRemmelKSJauchEC. 2009. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke40(1):77–85.
20.
LindonJCHolmesENicholsonJK. 2003. So what’s the deal with metabonomics?Anal Chem75(17):384A–91A.
21.
LiptonP. 1999. Ischemic cell death in brain neurons. Physiol Rev79(4):1431–568.
22.
LiuMZhouKLiHDongXTanGChaiY, and others. 2015. Potential of serum metabolites for diagnosing post-stroke cognitive impairment. Mol Biosyst11(12):3287–96.
23.
LumbrerasBPortaMMarquezSPollanMParkerLAHernandez-AguadoI. 2008. QUADOMICS: an adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of “-omics”-based technologies. Clin Biochem41(16–17):1316–25.
24.
MelaniAPantoniLCorsiCBianchiLMonopoliABertorelliR, and others. 1999. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke30(11):2448–54.
25.
MontanerJPerea-GainzaMDelgadoPRiboMChaconPRosellA, and others. 2008. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke39(8):2280–7.
26.
MorgensternLBLisabethLDMecozziACSmithMALongwellPJMcFarlingDA, and others. 2004. A population-based study of acute stroke and TIA diagnosis. Neurology62(6):895–900.
27.
NaccaratoMPizzutiDPetrosinoSSimonettoMFerigoLGrandiFC, and others. 2010. Possible anandamide and palmitoylethanolamide involvement in human stroke. Lipids Health Dis9:47.
28.
NicholsonJKLindonJC. 2008. Systems biology: metabonomics. Nature455(7216):1054–6.
29.
NicholsonJKLindonJCHolmesE. 1999. “Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29(11):1181–9.
30.
Pellegrini-GiampietroDEMannaioniGBagettaG. 2009. Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death. FEBS J276(1):2–12.
31.
SaengerAKChristensonRH. 2010. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem56(1):21–33.
32.
ShalhoubJDaviesKJHasanNThaparASharmaPDaviesAH. 2012. The utility of collaborative biobanks for cardiovascular research. Angiology63(5):367–77.
33.
ShalhoubJSikkelMBDaviesKJVorkasPAWantEJDaviesAH. 2014. Systems biology of human atherosclerosis. Vasc Endovascular Surg48(1):5–17.
34.
WangYWangYGMaTFLiMGuSL. 2014. Dynamic metabolites profile of cerebral ischemia/reperfusion revealed by (1)H NMR-based metabolomics contributes to potential biomarkers. Int J Clin Exp Pathol7(7):4067–75.
35.
WhiteleyWTsengMCSandercockP. 2008. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke39(10):2902–9.
36.
YangMWangSHaoFLiYTangHShiX. 2012. NMR analysis of the rat neurochemical changes induced by middle cerebral artery occlusion. Talanta88:136–44.
37.
ZhongCLvLLiuCZhaoLZhouMSunW, and others. 2014. High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population. PLoS One9(9):e107498.
38.
ZhuYGuoZZhangLZhangYChenYNanJ, and others. 2015. System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemia. Sci Rep5:17068.
